367 related articles for article (PubMed ID: 10500495)
1. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
4. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
Smaill JB; Fan JY; Denny WA
Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
6. Structure of the d(CGCGAATTCGCG)2 complex of the minor groove binding alkylating agent alkamin studied by mass spectrometry.
Majid AM; Smythe G; Denny WA; Wakelin LP
Mol Pharmacol; 2007 Apr; 71(4):1165-78. PubMed ID: 17251328
[TBL] [Abstract][Full Text] [Related]
7. DNA-directed alkylating agents. 4. 4-anilinoquinoline-based minor groove directed aniline mustards.
Gravatt GL; Baguley BC; Wilson WR; Denny WA
J Med Chem; 1991 May; 34(5):1552-60. PubMed ID: 2033580
[TBL] [Abstract][Full Text] [Related]
8. Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies.
Martin C; Ellis T; McGurk CJ; Jenkins TC; Hartley JA; Waring MJ; Thurston DE
Biochemistry; 2005 Mar; 44(11):4135-47. PubMed ID: 15766241
[TBL] [Abstract][Full Text] [Related]
9. Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues.
Ferguson LR; Denny WA
Mutat Res; 1995 Jun; 329(1):19-27. PubMed ID: 7539521
[TBL] [Abstract][Full Text] [Related]
10. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
11. DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
Prakash AS; Denny WA; Gourdie TA; Valu KK; Woodgate PD; Wakelin LP
Biochemistry; 1990 Oct; 29(42):9799-807. PubMed ID: 2271617
[TBL] [Abstract][Full Text] [Related]
12. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry studies of the binding of the minor groove-directed alkylating agent alkamin to AT-tract oligonucleotides.
Abdul Majid AM; Smythe G; Denny WA; Wakelin LP
Chem Res Toxicol; 2009 Jan; 22(1):146-57. PubMed ID: 19113942
[TBL] [Abstract][Full Text] [Related]
14. Differences in sequence selectivity of DNA alkylation by isomeric intercalating aniline mustards.
Prakash AS; Denny WA; Wakelin LP
Chem Biol Interact; 1990; 76(2):241-8. PubMed ID: 2225231
[TBL] [Abstract][Full Text] [Related]
15. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
Brooks N; McHugh PJ; Lee M; Hartley JA
Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
[TBL] [Abstract][Full Text] [Related]
16. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.
Marchini S; Gonzalez Paz O; Ripamonti M; Geroni C; Bargiotti A; Caruso M; Todeschi S; D'Incalci M; Broggini M
Anticancer Drug Des; 1995 Dec; 10(8):641-53. PubMed ID: 8595123
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA.
Henderson ND; Lacy SM; O'Hare CC; Hartley JA; McClean S; Wakelin LP; Kelland LR; Robins DJ
Anticancer Drug Des; 1998 Oct; 13(7):749-68. PubMed ID: 9807160
[TBL] [Abstract][Full Text] [Related]
18. Effect of nucleosome structure on DNA interstrand cross-linking reactions.
Millard JT; Spencer RJ; Hopkins PB
Biochemistry; 1998 Apr; 37(15):5211-9. PubMed ID: 9548752
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
Sunavala-Dossabhoy G; Van Dyke MW
Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
[TBL] [Abstract][Full Text] [Related]
20. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
